Gastroenterology

Journal PubWeight™ 26027.28‹?›

Top papers

Rank Title Year PubWeight™‹?›
1 Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. 2007 26.78
2 Functional bowel disorders. 2006 20.72
3 Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. 2008 15.86
4 The natural history of nonalcoholic fatty liver disease: a population-based cohort study. 2005 15.74
5 Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. 1976 15.65
6 Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. 2004 14.78
7 Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence. 2003 14.67
8 Steatohepatitis: a tale of two "hits"? 1998 13.21
9 MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. 2007 13.20
10 Antibodies to ribosomes in chronic active hepatitis. 1979 12.78
11 Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. 2011 12.09
12 Mechanisms of hepatic fibrogenesis. 2008 11.98
13 New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. 1999 11.94
14 Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. 1999 11.76
15 A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. 1990 11.22
16 Primary liver cancer: worldwide incidence and trends. 2004 11.21
17 Biology of incretins: GLP-1 and GIP. 2007 10.45
18 Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity ('celiac sprue'). 1992 10.44
19 Regional enteritis. 1954 10.27
20 Model for end-stage liver disease (MELD) and allocation of donor livers. 2003 10.11
21 Epidemiology of viral hepatitis and hepatocellular carcinoma. 2012 10.00
22 Colorectal cancer screening: clinical guidelines and rationale. 1997 9.70
23 Inflammatory bowel disease: etiology and pathogenesis. 1998 9.58
24 Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. 2005 9.44
25 Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C. 2002 9.35
26 Microbial influences in inflammatory bowel diseases. 2008 9.20
27 Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment. 2007 9.05
28 Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. 1994 8.79
29 The functional gastrointestinal disorders and the Rome III process. 2006 8.71
30 Functional bowel disorders in apparently healthy people. 1980 8.52
31 Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer. 2012 8.51
32 Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. 1997 8.51
33 Functional gastroduodenal disorders. 2006 8.51
34 Mucosal flora in inflammatory bowel disease. 2002 8.42
35 Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. 2000 8.41
36 A clinicopathologic study of enterocyte-adherent Escherichia coli: a cause of protracted diarrhea in infants. 1982 8.38
37 A diet low in FODMAPs reduces symptoms of irritable bowel syndrome. 2013 8.37
38 Hepatocellular carcinoma in cirrhosis: incidence and risk factors. 2004 8.36
39 The epidemiology of obesity. 2007 8.35
40 Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment. 1988 8.27
41 Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. 2001 8.09
42 Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. 2010 8.05
43 A prospective trial comparing small bowel radiographs and video capsule endoscopy for suspected small bowel disease. 2002 7.97
44 Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study. 2010 7.86
45 A standardized mouse model of Helicobacter pylori infection: introducing the Sydney strain. 1997 7.72
46 Hapten-induced model of chronic inflammation and ulceration in the rat colon. 1989 7.59
47 Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies. 1997 7.58
48 Obesity, inflammation, and insulin resistance. 2007 7.54
49 Early indicators of prognosis in fulminant hepatic failure. 1989 7.43
50 Campylobacter pylori and peptic ulcer disease. 1989 7.42
Next 50